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ABSTRACT HIV and sexually-transmitted diseases (STDs) represent a sig-
nificant public health problem worldwide. We analyzed the seroprevalence 
and risk factors for HIV, hepatitis B and syphilis in populations with high-risk 
behaviors in Croatia. During a three-year period, a total of 443 men who 
have sex with men (MSM) / bisexual persons, sex workers (SW) / clients of 
SW, persons with multiple sexual partners, and persons with a history of STD 
were tested for the presence of HIV, hepatitis B virus (HBV), and Treponema 
pallidum (syphilis) antibodies within the framework of second generation 
HIV surveillance. Participants were recruited from 11 Croatian counties, the 
vast majority among clients of voluntary counselling and testing centers. 
The overall prevalence of HIV, HBsAg, anti-HBc, and syphilis was 1.4%, 2.6%, 
12.1%, and 3.4%, respectively. HBV and syphilis seroprevalence differed sig-
nificantly between, genders with higher prevalence among men (anti-HBc 
13.8% vs. 5.7%, P=0.043; syphilis 4.4% vs. 0%; P=0.049), as well as between 
age groups, with a steady increase according to age. Participants with a histo-
ry of STD were more often seropositive than participants who did not report 
STD (HBsAg 8.2% vs. 1.0%, P=0.002; anti-HBc 32.4% vs. 6.4%, P<0.001; syphilis 
12.0% vs. 1.7%, P<0.001). Syphilis seroprevalence was higher in homo / bi-
sexual persons (12.2%) compared with heterosexual persons (1.2%, P<0.001). 
logistic regression showed that history of STD was a significant risk factor for 
hepatitis B (HBsAg AOR=6.229, 95% CI=1.491-26.022; anti-HBc AOR=5.872, 
95% CI=2.899-11.896) and syphilis seropositivity (AOR=5.572, 95% CI=1.751-
17.726), while homo / bisexual behavior was associated with syphilis seropos-
itivity (AOR=12.820, 95% CI=3.688-44.557). Our results highlight the impor-
tance of continuing STDs screening and prevention in at-risk populations.
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INTRODUCTION
HIV and sexually-transmitted diseases (STDs) con-
tinue to be a significant public health problem world-
wide. The World Health Organization estimates that 
about 37 million of the world population is chroni-
cally infected with human immunodeficiency virus 
(HIV), 350 million with hepatitis B virus (HBV) (1), and 
ACTA DERMATOVENEROLOGICA CROATICA
315
about 18 million become infected with Treponema 
pallidum (syphilis) every year (2). Prevalence varies by 
geographic region and population group. Men who 
have sex with men (MSM) and commercial sex work-
ers (CSW) remain high-risk groups for acquisition of 
HIV and other STDs, due to continuing high risk sexual 
behaviors such as multiple sexual partners, inconsis-
tent condom use and co-infection with another STDs 
(3-7). In heterosexual persons, factors associated with 
sexual transmission include unprotected sex with an 
infected partner or with multiple sexual partners, as 
well as a history of another STD (8,9).
Although incidence of HIV decreased globally in 
recent years, the HIV epidemic in MSM and bisexual 
persons continue to progress in most countries (10-
12). In europe, HIV seroprevalence among MSM is re-
ported to be 1-17% (13,14). In CSW, seroprevalence 
differed greatly between countries and even within 
the same country (1.08-24.70%) (15,16). HBV has 
been recognized as an important STD among MSM 
and CSW for many years (17), of whom 3.2-27.1% 
showed serologic evidence of HBV infection (anti-
HBc antibodies) (14,18,19) and <1-7% had chronic 
infection (18-21). In addition to sexual risk factors, in-
jecting drug use (IDU) is still an important risk factor 
for HBV transmission (8). 
Over the past decade, syphilis has re-emerged in 
many european countries, mostly due to increased 
incidence among MSM with high risk sexual behavior 
(6). Seroprevalence rates of syphilis among MSM and 
CSW varied from 0.5% to a high 36.9% (16,18).
In Croatia, the surveillance system of HIV and 
other STI is based on case reporting and successive 
cross-sectional studies of populations under height-
ened risk within the framework of second generation 
HIV surveillance. The aim of this study was to ana-
lyze the prevalence and risk factors for HIV infection, 
hepatitis B and syphilis in populations with high-risk 
behaviors. 
PATIENTS AND METHODS
During a three-year period (2011-2013), a seroepi-
demiological survey of HIV, hepatitis B, and syphilis 
in groups with high-risk behaviors (MSM, homo/bi-
sexual persons, CSW/clients of CSW, persons with 
multiple sexual partners, IDUs) was conducted in 11 
Croatian counties within the framework of second 
generation HIV surveillance. Study participants were 
recruited with the help of epidemiologists and non-
governmental organizations that provide services 
for most-at-risk populations, mostly among clients 
of voluntary counselling and testing centers at coun-
ties public health institutes (convenience sampling). 
After obtaining informed consent for participation 
in the study, each participant filled an anonymous 
questionnaire regarding sociodemographic data 
and risk-behaviors, followed by venipuncture for HIV, 
hepatitis B, and syphilis testing. All study participants 
received counseling and education on HIV and other 
STDs (22,23).
Serologic tests were performed at the laboratory 
for Serology, Croatian Institute of Public Health (CIPH) 
using commercial diagnostic tests: HIV p24Ag/anti-
HIV1/2, HBsAg, and anti-HBc using enzyme-linked 
fluorescent assay (elFA; Mini Vidas, Marcy l’etoile, 
France) and syphilis using enzyme-linked immuno-
sorbent assay (elISA; euroimmun, lübeck, Germany) 
and western blot test (WB; euroimmun, lübeck, Ger-
many) for confirmation of positive results. All HIV 
elFA reactive samples were confirmed using a west-
ern blot at the University Hospital for Infectious Dis-
eases “Dr Fran Mihaljević”, Zagreb.
The study was approved by the ethics Committee 
of the CIPH.
Statistical analysis
Man-Whitney U and Fisher’s exact tests were used 
to compare differences between groups of ordinal 
and nominal variables, respectively. Assumption of 
binomial distribution was used for confidence inter-
vals calculation. The level of statistical significance 
was set to α=0.05. For statistical analysis, STATA/IC 
version 11.2 (StataCorp lP, USA) software was used.
RESULTS
Sociodemographic characteristics and 
risk behaviors of study population 
The study included a total of 443 participants. 
There were 354 (79.9%) men and 89 (20.1%) women 
aged 18-62 years (Figure 1). One hundred and one 
participants (22.8%) were single/separated, 185 
(41.7%) were unemployed, 153 (34.5%) had ever in-
jected drugs, and 276 (62.3%) reported a history of 
travelling/staying abroad for extended periods. All 
participants reported one or more high risk sexual 
behaviors: 99 (22.3%) MSM / bisexual orientation, 276 
(62.3%) having multiple sexual partners (more than 
two partners in previous 12 months), 22 (4.9%) SW, 
103 (23.3%) clients of SW, and 305 (68.0%) reported 
a history of STD. 
Seroprevalence results
The overall prevalence rates of HIV, HBsAg, anti-
HBc, and syphilis antibodies were 1.4% (95% CI=0.5-
2.9), 2.6% (95% CI=1.3-4.5), 12.1% (95% CI=9.1-15.5), 
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Table 1. Prevalence of HIV, hepatitis B  and syphilis according to participants’ characteristics 

















Gender   0.605 0.131 0.043 0.049
     Male 6/349 (1.7) 11/339 (3.2) 40/340 (13.8) 15/343 (4.4)
     Female 0/88 (0) 0/87 (0) 5/87 (5.7) 0/88 (0)
Age (years) 0.827 0.048 <0.001 0.004
     < 30 3/155 (1.9) 2/153 (1.3) 5/153 (3.3) 1/155 (0.6)
     30 - 39 2/181 (1.1) 3/180 (1.7) 24/181 (13.3) 5/178 (2.8)
     40 - 49 1/72 (1.4) 5/68 (7.4) 17/68 (25.0) 6/69 (8.7)
     50+ 0/31 (0) 1/27 (3.7) 6/27 (22.2) 3/31 (9.7)
Marital status 0.505 0.488 0.805 0.283
     Single 0/76 (0) 0/74 (0) 9/74 (12.2) 5/75 (6.7)
     Married 4/209 (1.9) 6/203 (3.0) 22/204 (10.8) 7/207 (3.4)
     Steady partner 1/119 (0.8) 3/117 (3.4) 17/117 (14.5) 3/117 (2.6)
     Divorced/widowed 1/35 (2.9) 1/34 (2.9) 4/34 (11.8) 0/34 (0)
employment status 0.703 1.000 0.550 0.003
     employed 3/249 (1.2) 6/246 (2.4) 28/246 (11.4) 12/181 (6.6)
     Unemployed 3/185 (1.6) 5/177 (2.8) 24/178 (13.5) 3/247 (1.2)
Sexual orientation 0.108 0.703 1.000 <0.001
     Heterosexual 3/346 (0.9) 8/339 (2.4) 42/340 (12.4) 4/341 (1.2)
     Homo/bisexual 3/91 (3.3) 3/87 (3.4) 10/87 (11.5) 11/90 (12.2)
History of STDs 1.000 0.002 <0.001 <0.001
     Yes 3/305 (1.0) 6/73 (8.2) 24/74 (32.4) 9/75 (12.0)
     No 1/76 (1.3) 3/298 (1.0) 19/298 (6.4) 5/302 (1.7)
Sex work 1.000 0.446 0.168 0.550
     Yes 0/22 (0) 1/22 (4.5) 5/22 (22.7) 1/22 (4.5)
     No 6/415 (1.4) 10/404 (2.5) 47/405 (11.6) 14/409 (3.4)
Paying for sex 1.000 1.000 0.730 1.000
     Yes 1/103 (1.0) 2/101 (2.0) 11/101 (10.9) 3/101 (3.0)
     No 5/334 (1.5) 9/325 (2.8) 41/326 (12.6) 12/330 (3.6)
Number of sexual 
partners
0.133 0.472 0.904 0.013
     <2 0/152 (0) 3/149 (2.0) 18/150 (12.0) 2/149 (1.3)
     2-5 5/196 (2.6) 7/192 (3.6) 24/192 (12.5) 6/193 (3.1)
     >5 1/79 (1.3) 11/417 (2.6) 8/76 (10.5) 7/79 (8.9)
Injecting drug use 0.670 0.207 <0.001 0.003
     Yes 1/153 (0.7) 6/151 (4.0) 35/152 (23.0) 14/281 (5.0)
     No 5/284 (1.8) 5/276 (1.8) 17/276 (6.2) 0/150 (0)
History of travelling 0.092 0.987 0.759 0.778
     Yes 6/276 (2.2) 4/153 (2.6) 32/269 (11.9) 10/272 (3.7)
     No 0/156 (0) 7/269 (2.6) 20%153 (13.1) 4/154 (2.6)
and 3.4% (95% CI=1.9-5.6), respectively. Seropreva-
lence results according to the participant’s character-
istics are presented in Table 1. Anti-HBc and syphilis 
seroprevalence differed among genders with higher 
prevalence among men (anti-HBc 13.8% vs. 5.7%, 
P=0.043; syphilis 4.4% vs. 0.0%; P=0.049). There were 
significant differences in hepatitis B and syphilis prev-
alence between age groups. Anti-HBc antibodies in-
creased progressively with age from 3.3% in persons 
less than 30 years old to 25.0% in persons aged 40-49 
years and remained stable thereafter, while preva-
lence of HBsAg was highest in the 40-49-year age 
group (7.4%) compared with 1.3-3.7% in other age 
groups. Homo / bisexual persons showed higher se-
roprevalence of syphilis (12.2%) compared with het-
erosexual persons (1.2%, P<0.001). Participants with 
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history of STD were more often seropositive than 
participants who did not report STD (HBsAg 8.2% 
vs. 1.0%, P=0.002; anti-HBc 32.4% vs. 6.4%, P<0.001; 
syphilis 12.0% vs. 1.7%, P<0.001). In addition, syphi-
lis seroprevalence was associated with the number 
of sexual partners and varied from 1.3% in persons 
who reported less than two sexual partners to 8.9% 
in persons who reported more than five sexual part-
ners in the previous 12 months (P=0.013). Anti-HBc 
and syphilis prevalence correlated with IDU (anti-
HBc 23.0% vs. 6.2%, P<0.001; syphilis 5.0% vs. 0.0%, 
P=0.003). Marital status, employment status, history 
of paid sex, and history of travelling / staying abroad 
for extended periods were not associated with HIV, 
HBsAg, anti-HBc, or syphilis seropositivity.
Analyzing sexual risk behaviors, results of the logis-
tic regression showed that history of STD was a signif-
icant risk factor for HBsAg (OR=8.806, 95% CI=2.148-
36.107; AOR=6.229, 95% CI=1.491-26.022), anti-
HBc (OR=7.048, 95% CI=3.596-13.814; AOR=5.872, 
95% CI=2.899-11.896), and syphilis seropositivity 
(OR=8.100, 95% CI=2.628-24.956; AOR=5.572, 95% 
CI=1.751-17.726), while homo / bisexual behavior 
was a significant risk factor for syphilis seropositivity 
(OR=11.731, 95% CI=3.639-37.808; AOR=12.820, 95% 
CI=3.688-44.557). In addition, syphilis seroprevalence 
was associated with the number of sexual partners 
(consecutive increase for one partner, OR=1.065, 95% 
CI=1.029-1.102; AOR=1.074, 95% CI=1.031-1.118). 
Anti-HBc seroprevalence correlated with male gender 
(OR=2.632, 95% CI=1.014-6.849) and IDU (OR=4.557, 
95% CI=2.453-8.465; AOR=5.618, 95% CI=2.804-
11.256) (Table 2 and Table 3).
DISCUSSION
In persons with high risk sexual behavior enrolled 
in this study, HIV prevalence was reported to be 1.4% 
overall, and higher among MSM (3.3%). With regard 
to the prevalence rates in MSM and bisexual persons 
with previous Croatian studies, the seroprevalence 
found in this study was comparable with the results 
of the studies conducted in 2010 and 2007 (2.8% and 
3%, respectively) (23,24), while the seroprevalence 
was higher (4.5%) in the 2006 study (25). 
The results of the SIAlON Project study, conduct-
ed among MSM in six cities in Southern and eastern 
europe showed prevalence rates of 2.6% in Prague 
(Czech Republic), 4.6% in Bucharest (Romania), 5.1% 
in ljubljana (Slovenia), 6.0% in Bratislava (Slovakia), 
11.8% in Verona (Italy), and 17.0% in Barcelona (Spain) 
(26). lower prevalence rates were reported in two cit-
ies in Moldova (Chisinau 2%, Balti 1%) (14,16). In this 
study, 0.9% heterosexual persons were found to be 
HIV seropositive, which is within the range of previous 
Croatian studies (0.6%-1.2%) (23,25). Although homo 
/ bisexual persons showed higher seropositivity than 
Figure 1. Distribution of study participants according to 
age and gender
Table 2. logistic regression for the risk of HIV, hepatitis B and syphilis seropositivity 
HIV HBsAg Anti-HBc Syphilis
Characteristic OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Male vs female gender NAa NA NA NA 2.632 1.014-6.849 NA NA
Age (one year increase) 0.968 0.876 - 1.070 1.058 1.001 - 1.118 1.075 1.043 - 1.107 1.089 1.040 - 1.141
Homo/bisexual vs 
heterosexual orientation
3.897 0.773 - 19.643 1.478 0.384 - 5.691 0.921 0.442 - 1.919 11.731 3.639 - 37.808
History of STDs (yes vs no) 1.342 0.137 - 13.086 8.806 2.148 - 36.107 7.048 3.596 - 13.814 8.100 2.628 - 24.956
Sex work (yes vs no) NA NA 1.876 0.229 - 15.352 2.240 0.789 - 6.353 1.343 0.168 - 10.708
Paying for sex (yes vs no) 0.645 0.074 - 5.585 0.709 0.151 - 3.338 0.849 0.419 - 1.721 0.811 0.224 - 2.933
Number of sexual 
partners
1.001 0.909-1.003 0.959 0.814 - 1.130 0.972 0.911 - 1.037 1.065 1.029 - 1.102
Injecting drug use  
(yes vs no)
0.367 0.042 - 3.170 2.243 0.673 - 7.475 4.557 2.453 - 8.465 NA NA
aNA=not applicable
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heterosexuals (3.3% vs. 0.9%), the difference was not 
significant. This finding might be due to the very small 
number of HIV seropositive subjects in our study.
Regarding hepatitis B, the overall rate of anti-HBc 
in this study was 12.1%, which is almost two times 
higher than that reported in the Croatian general pop-
ulation (7.0%) (27) as well as in the MSM (7.7%) (25). In 
groups with high risk sexual behavior within europe, 
HBV prevalence showed significant geographical 
variations from 3.2%-9.1% in Moldova (14,16), 7% in 
Denmark (28), 7.6% in Albania (15), 12% in Scotland 
(19), to a high 27.1% in Germany (18) and 28.9% in 
Belgium (29). The prevalence of current HBV infection 
(HBsAg positive) of 2.6% found in this study is within 
the european range (<1-7%) (19-21,29).
Syphilis seropositivity found in Croatia during 
2011-2013 was lower (3.4%) than in the 2010 (7.6%) 
(24) and 2006 studies (10.6%) (25), as well as in the 
majority of other european studies: Germany 36.9%, 
Italy 21.6%, Belgium 12.5%, Russia 12%, Moldova 6.1-
12.1% and Albania 6.5% (14-16,18,29-31). The only 
exception to this trend was found in Balti, Moldova, 
where a very low prevalence of syphilis in MSM was 
found (0.5%) (14).
With respect to gender, our study showed sig-
nificant differences in HBV and syphilis among gen-
ders: anti-HBc antibodies were found in 13.8% men 
and 5.7% women, while all participants with positive 
syphilis serology (3.4%) were male. A Turkish study on 
the prevalence of syphilis conducted among newly 
diagnosed HIV / AIDS patients showed similar results, 
i.e. found syphilis seropositivity only in men (32). 
However, in some countries gender differences were 
reported with female predominance. For example, in 
Moldova, seroprevalence of HBV was higher in female 
SW than in MSM (8.9-9.1% vs. 3.2-5.7%), while syphilis 
seropositivity in female SW was 6.1-8.4% compared 
wiht 0.1-12.1% in MSM (14,16). Although a difference 
in HIV seroprevalence between genders was also ob-
served in this study (no women were seropositive 
compared with 1.7% men), this difference was not 
significant, probably due to the small number of se-
ropositive subjects. 
Seropositivity to HBV and syphilis in Croatia was 
strongly age dependent. The possible explanations 
for a steady increase in prevalence of hepatitis B 
among older clients tested include longer lifetime 
exposure to HBV as well as cohort effect of the child-
hood vaccination program (universal infant immuni-
zation implemented in 1999 at national level) which 
altered hepatitis B epidemiology trends and shifted 
the majority of HBV infections to older age.
HIV seropositive persons were equally distributed 
in the age group below 50. In the SIAlON Project, 
prevalence of HIV among people of over 25 years 
of age was significantly higher than among people 
younger than 25 years (9.6% vs. 3.5%) (26).
Regarding high risk sexual behavior, HBV positiv-
ity in this study was significantly related to a history 
of STD. Although a higher seroprevalence of anti-HBc 
was found in participants who reported sex work than 
in those who did not (22.7% vs. 11.6%), the difference 
was not significant. Probability of being syphilis sero-
positive was significantly higher in persons who re-
ported homo / bisexual orientation, a history of STDs, 
and higher number of sexual partners.
The relationship between HIV, HBV, and syphilis 
with IDU among persons with high risk sexual behav-
ior was observed in many studies (33-35). A Dutch 
study found HIV seropositivity to be 13.6% in IDU 
CSW compared with 5.7% in non-IDU CSW (35). 
lifetime IDU was common in persons tested in 
this study (34.5%). Participants who reported life-
time IDU were significantly more likely to be HBV and 
syphilis seropositive compared with those who did 
not (23.0% vs. 6.2% and 5.0% vs. 0%, respectively). 
There was no difference in HIV seropositivity among 
IDUs and non-IDUs (0.7% and 1.8%). In contrast, a 
Russian study found no association of IDU and STD / 
HIV among Moscow female SW (33).
Table 3. logistic regression for the risk of HIV, hepatitis B and syphilis seropositivity after adjusting for age 
and gender 
HIV HBsAg Anti-HBc Syphilis
Characteristic AORa 95%CI AOR 95%CI AOR 95%CI AOR 95%CI
Homo/bisexual vs 
heterosexual orientation
3.103 0.609 - 15.792 1.353 0.346 - 5.299 0.928 0.430 - 1.998 12.820 3.688 - 44.557
History of STDs (yes vs no) 1.702 0.151 - 19.142 6.229 1.491 - 26.022 5.872 2.899 - 11.896 5.572 1.751 - 17.726
Sex work (yes vs no) NAb NA 2.212 0.252 - 19.430 2.459 0.791 - 7.641 1.449 0.160 - 13.105
Paying for sex (yes vs no) 0.513 0.058 - 4.486 0.389 0.078 - 1.943 0.474 0.216 - 1.041 0.368 0.093 - 1.453
Number of sexual partners 1.001 0.902 - 1.108 0.943 0.774 - 1.149 0.968 0.897 - 1.040 1.074 1.031 - 1.118
Injecting drug use (yes vs no) 0.327 0.037 - 2.853 2.059 0.600 - 7.067 5.618 2.804 - 11.256 NA NA
aAOR=adjusted for age and gender; NAb=not applicable
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Our study has some limitations. As a result of a con-
venience sample, inherent bias should be taken into 
account. Due to the small numbers of participants in 
some risk groups (SW) as well as a small number of 
HIV-positive participants, some calculations should 
be interpreted with caution. Despite these limita-
tions, our results provide new data on the epidemiol-
ogy, including risk factors for STD, in key population 
groups with different high risk behaviors in Croatia.
CONCLUSIONS
The results of this study showed that HIV serop-
revalence did not change substantially, while syphilis 
seroprevalence decreased in Croatia over the last de-
cade. The prevalence of hepatitis B was the highest 
of the STDs screened. A higher hepatitis B prevalence 
found in this study compared with previous Croatian 
studies probably reflects a high proportion of per-
sons who reported lifetime IDU. Although prevalence 
of some STDs in groups with high risk sexual behavior 
has declined, a high proportion of sexual risk behav-
iors in these population groups highlight the impor-
tance of continuing STDs screening and prevention.
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